Literature DB >> 9048173

A family practice residency cervical screening project: perceived screening barriers.

R Branoff1, K Santi, J K Campbell, R Roetzheim, M Oler.   

Abstract

BACKGROUND AND OBJECTIVES: A community-based family practice residency program initiated a cervical screening project to provide free Pap smears to women who had not had one in 3 years. The research identified reasons why patients had not been screened within the past 3 years.
METHODS: A total of 214 consecutive participants in the free Pap smear clinic completed questionnaires. The questionnaire asked about reasons why screening had not occurred over the last 3 years.
RESULTS: Altogether, 65.4% of the study group reported cost-related factors as barriers to participation; 37.9% cited either scheduling concerns, fear, or embarrassment; and 36% cited misinformation issues about either screening recommendations, effectiveness of treatment, or disease presentation.
CONCLUSIONS: Strategies to increase participation in Pap smear screening clinics may include increasing availability of free or low-cost screening examinations, increasing time efficiency and scheduling flexibility of examinations, and making efforts to mitigate the fear and embarrassment associated with the exam.

Entities:  

Mesh:

Year:  1997        PMID: 9048173

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  3 in total

1.  Factors important in promoting cervical cancer screening among Canadian women: findings from the 1996-97 National Population Health Survey (NPHS).

Authors:  C J Maxwell; C M Bancej; J Snider; S A Vik
Journal:  Can J Public Health       Date:  2001 Mar-Apr

2.  Application of the Carolina Framework for Cervical Cancer Prevention.

Authors:  Jennifer L Moss; Schatzi H McCarthy; Melissa B Gilkey; Noel T Brewer
Journal:  Gynecol Oncol       Date:  2013-12-10       Impact factor: 5.482

Review 3.  Cervical cancer screening and psychosocial barriers perceived by patients. A systematic review.

Authors:  Alicja Bukowska-Durawa; Aleksandra Luszczynska
Journal:  Contemp Oncol (Pozn)       Date:  2014-06-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.